Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Healthcare & Medical Investment Corp stock PB Ratio (=1.02) is close to 5-year low of 0.96.
The historical rank and industry rank for Healthcare & Medical Investment's PB Ratio or its related term are showing as below:
TSE:3455'
s PB Ratio Range Over the Past 10 Years
Min: 0.74 Med: 1.14 Max: 1.86
Current: 0.97
During the past 11 years, Healthcare & Medical Investment's highest PB Ratio was 1.86. The lowest was 0.74. And the median was 1.14.
TSE:3455's PB Ratio is ranked worse than 63.28% of 915
companies
in the REITs industry
Industry Median: 0.86
vs TSE:3455: 0.97
During the past 12 months, Healthcare & Medical Investment's average Book Value Per Share Growth Rate was 0.30% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was -0.20% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was 0.20% per year.
During the past 11 years, the highest 3-Year average Book Value Per Share Growth Rate of Healthcare & Medical Investment was 0.40% per year. The lowest was -0.20% per year. And the median was 0.20% per year.
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
Healthcare & Medical Investment PB Ratio Related Terms
Healthcare & Medical Investment PB Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the REIT - Healthcare Facilities subindustry, Healthcare & Medical Investment's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Healthcare & Medical Investment PB Ratio vs REITs Industry
For the REITs industry and Real Estate sector, Healthcare & Medical Investment's PB Ratio distribution charts can be found below:
* The bar in red indicates where Healthcare & Medical Investment's PB Ratio falls into.
Healthcare & Medical Investment PB Ratio Calculation
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Healthcare & Medical Investment (TSE:3455) has a PB Ratio of 0.98 as of Aug. 01, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Healthcare & Medical Investment and its competitors. This is 14% below median its historical median of 1.14. Over the past decade, Healthcare & Medical Investment's PB Ratio has ranged from 0.74 to 1.86. According to the industry distribution chart, Healthcare & Medical Investment ranks #579 out of 915 companies in the REITs industry, placing it in the top 63.3%.
Is Healthcare & Medical Investment's PB Ratio too high?
Healthcare & Medical Investment's current PB Ratio of 0.98 is 14% below median its 10-year median of 1.14. Over the past 10 years, this metric has ranged from a low of 0.74 to a high of 1.86. The REITs industry median PB Ratio is 0.86. Healthcare & Medical Investment's value of 0.98 is 14% above this industry median. Based on the distribution chart, Healthcare & Medical Investment ranks #579 out of 915 companies in the REITs industry, which is below the industry midpoint. Overall, Healthcare & Medical Investment has a GF Score™ of 59/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Healthcare & Medical Investment's PB Ratio compare to WELL and VTR?
According to the REITs industry distribution chart, Healthcare & Medical Investment ranks #579 out of 915 companies for PB Ratio. This places Healthcare & Medical Investment in the lower half of its industry. The industry median PB Ratio is 0.86. Healthcare & Medical Investment's value of 0.98 is 14% above this benchmark. Historically, Healthcare & Medical Investment's own PB Ratio has ranged from 0.74 to 1.86 over the past decade. While the company's 10-year median is 1.14 vs. the industry median of 0.86, Healthcare & Medical Investment has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a REITs company?
The median PB Ratio among REITs companies is 0.86, based on 915 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Healthcare & Medical Investment's current PB Ratio of 0.98 is 14% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Healthcare & Medical Investment and its competitors. For the REITs industry, the median PB Ratio is 0.86 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Healthcare & Medical Investment's current PB Ratio is 0.98, which is 14% below median its own 10-year median of 1.14. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Healthcare & Medical Investment stock overvalued right now?
Based on GuruFocus' analysis, Healthcare & Medical Investment (TSE:3455) is currently considered Modestly Undervalued. The stock's GF Value™ is 円129,254.71, compared to a current price of 円105,400.00 — trading 18.5% below its estimated fair value. The current PB Ratio is 0.98, which is 14% below median its 10-year median of 1.14 and 14% above the REITs industry median of 0.86. Healthcare & Medical Investment's overall GF Score™ is 59/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Healthcare & Medical Investment (TSE:3455), the current PB Ratio is 0.98 as of Aug. 01, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Healthcare & Medical Investment (TSE:3455) Overvalued in 2026?
Based on GuruFocus' analysis, Healthcare & Medical Investment stock appears to be undervalued.
The current stock price of 円105,400.00 is trading 18.5% below its estimated GF Value™ of 円129,254.71.
GuruFocus considers Healthcare & Medical Investment to be Modestly Undervalued.
Key valuation signals for TSE:3455:
PB Ratio: 0.98 (14% below median its 10-year median of 1.14)
GF Value™: 円129,254.71 vs. price of 円105,400.00 (18.5% below fair value)
Industry Position: 14% above the REITs median (#579 of 915)
No single metric tells the full story. See the TSE:3455 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Healthcare & Medical Investment Corp is an investment company, which invests in nursing homes facilities and medical related real properties. The company aims to achieve stable earnings from mid- to long-term perspectives through investment in real estate and other related assets. The firm primarily invests in facilities and buildings for the elderly, as well as medical related facilities.
59GF Score
Get the complete analysis for TSE:3455
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:3455 has been successfully added to your 
